Thailand In-Vitro Diagnostics Market is predicted to reach USD 1.63 Billion by 2030

According to the study by Next Move Strategy Consulting, the Thailand In-Vitro Diagnostics Market size is predicted to reach USD 1.63 billion, at a CAGR of 6.3% by 2030.

Request a FREE Sample: https://www.nextmsc.com/thailand-in-vitro-diagnostic-market/request-sample

The prevalence of non-communicable diseases significantly drives the growth of the in-vitro diagnostics market in Thailand.

The growth in aging population in Thailand boosts the demand for advanced diagnostics solutions such as in-vitro diagnostics.

The promising players operating in the Thailand in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.